HOME >> MEDICINE >> NEWS
OHSU scientists test medication to treat involuntary weight loss

PORTLAND, Ore. Scientists at Oregon Health & Science University, in collaboration with Neurocrine Biosciences Inc., have successfully tested a research medication that both stimulates appetite and reduces metabolic rate in preclinical trials. Neurocrine, which developed the test medication for this research, is now developing a related medication that will likely be tested in patients suffering from a common, disease-related form of malnutrition and involuntary weight loss called cachexia. The results of the research are published in the current online edition of the journal Endocrinology.

"We've all seen AIDS and cancer patients who lose their appetites and suffer from involuntary weight loss. They lose muscle mass and become very frail as their disease progresses -- this is what we refer to as cachexia," explains Daniel Marks, M.D., Ph.D., a member of the OHSU Center for Weight Regulation and Associated Disorders and an assistant professor of pediatric endocrinology in the OHSU School of Medicine. "Cachexia is a very serious and currently untreatable disorder that can often impede the battle against the related disease. For instance, cancer patients who are malnourished due to cachexia cannot undergo intense chemotherapy simply because their bodies are too frail to handle it. If we can prevent cachexia and keep these patients from deteriorating physically, it gives them a greater chance of surviving the disease they are fighting."

This latest research breakthrough is based on earlier studies that demonstrated how a receptor on certain brain cells -- called the MC4 receptor -- can influence metabolism and appetite. Previous research involving mice demonstrated that when this specific cell receptor is blocked by delivering medications directly to the brain, the effects of cachexia are reversed. The animals' appetite and weight increase while their metabolic rate decreases. The next step in the research process, and the goal of this study, wa
'"/>

Contact: Jim Newman
newmanj@ohsu.edu
503 494-8231
Oregon Health & Science University
29-Mar-2005


Page: 1 2 3

Related medicine news :

1. Earlier use of prostate cancer vaccines urged by Hopkins scientists
2. Tobacco industry pays scientists to challenge secondhand smokes link to infant death risk
3. Schepens scientists regenerate optic nerve for the first time
4. OHSU scientists develop MRI approach to improve breast cancer detection
5. UCLA neuroscientists pinpoint new function for mirror neurons
6. Jefferson scientists uncover potential trigger of diabetic kidney disease
7. Johns Hopkins scientists receive presidential medals
8. UCLA brain scientists crack mystery of how alcohol causes intoxication
9. Wisconsin scientists grow critical nerve cells
10. Jefferson scientists help explain statins effects in Alzheimers disease
11. Jefferson scientists find zinc may help prevent esophageal, oral cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2020)... ... 28, 2020 , ... Confluent Health is proud to announce ... company since 1985 specializing in the treatment of orthopedic, sports, and work-related injuries ... 30 years ago, we have been committed to providing excellent quality of patient ...
(Date:3/22/2020)... ... March 21, 2020 , ... The ... Modular Home Builders Association (MHBA), have been working with state and federal officials ... been advocating for greater use of modular construction to address the nation’s affordable ...
(Date:3/20/2020)... ... ... My heart goes out to those across our nation and around the ... recently through similar circumstances - underlying conditions compounded by a virus – I truly ... negative emotions just like many have: fear, anxiety, uncertainty. In contrast, I would like ...
(Date:3/19/2020)... ... March 19, 2020 , ... For weeks, SignatureCare Emergency Center has ... Earlier this week, it announced that while we are still short of some critical ... not wait for our preparedness measures to be complete. , The Houston, TX based ...
(Date:3/19/2020)... Va. (PRWEB) , ... March 20, 2020 , ... With ... conducts clinical trials will look different than they do today. Be ready to implement ... Trial Requirements management report shows readers how to leverage the revised guidelines’ quality-by-design approaches, ...
Breaking Medicine News(10 mins):
(Date:3/27/2020)... , ... March 27, 2020 , ... ... college recruitment platform based on students' holistic portfolios, revealed that college-bound young adults ... This pandemic is creating huge new barriers to high school senior’s path to ...
(Date:3/22/2020)... ... 21, 2020 , ... As the spread of Coronavirus (COVID-19) ... Thoracic Medicine and Surgery, and the Temple Lung Center have taken proactive steps ... platform and triage/care coordination services. Temple is now enrolling patients, faculty, staff, frontline ...
(Date:3/20/2020)... ... 20, 2020 , ... Users who have tested positive for COVID-19 can anonymously ... of detailed location information, such as a specific building on campus or a local ... the virus. The app will also help people to more easily recall where they’ve ...
Breaking Medicine Technology:
Cached News: